Arthritis Juvenile Rheumatoid

• EMA withdrawal · 2021-01-29
  EMA Withdrawn: Halimatoz (adalimumab) — Sandoz GmbH

  The EMA withdrew Halimatoz (adalimumab) supplied by Sandoz GmbH from the market.

• EMA withdrawal · 2020-03-25
  EMA Withdrawn: Kromeya (adalimumab) — Fresenius Kabi Deutschland GmbH

  EMA has withdrawn Kromeya (adalimumab) from Fresenius Kabi Deutschland GmbH, effective 2019, affecting multiple inflammatory diseases.